- Staat
- NC
- Alter
- 1,5
- Geschlecht
- M
- Eingang
- 04.03.2022
- Impfdatum
- 02.03.2022
- Beginn
- 02.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Neurological examination normal
Pyrexia
Seizure
Symptomtext
3/2/2022 (day of immunizations): fever onset at 18:30. Around 11:40 that night, 60-90 sec of convulsions, self-resolved, T102.4. Parents called EMS and infant was transported to local ED. Febrile on arrival (T101.5) to ED. No further convulsions and normal neurological exam.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 24.02.2022
- Impfdatum
- 10.02.2022
- Beginn
- 22.02.2022
- Tage bis Beginn
- 12,0
- Dosis
- 2
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Condition aggravated
Electroencephalogram
Seizure
Symptomtext
Patient with known seizure disorder but has been seizure free for almost 18 months, had seizure on 2/22/21, 12 days after immunizations. Parent now realized that he also had seizures following other vaccinations. Had seizure within 2 weeks of varivax #1 in Feb 2019 and Pentacel #4 was given 4/5/19 and had seizure on 4/24/19. Mom did not correlate seizures at the time in 2019 so was not mentioned then. No seizures until 9/11/2018 and first 3 Pentacel vaccines were given 3/5/18, 5/8/18 and 8/6/18. Seizure on 2/22/21 was typical for him, needed diastat to stop seizure at 4.5 minutes. No other intervention needed and patient has been back to his baseline since.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- scheduled for repeat EEG in March 2022
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- congenital hydrocephalus with VP shunt, seizure disorder, mild-moderate developmental delays, exotropia
- Andere Medikamente
- keppra, CBD oil, multivitamin
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 32,0
- Geschlecht
- M
- Eingang
- 01.08.2022
- Impfdatum
- 26.07.2022
- Beginn
- 27.07.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Chest discomfort
Chest pain
Symptomtext
Systemic: Chest Tightness / Heaviness / Pain-Medium, Additional Details: Patient called regarding new onset of chest pain and was referred to get evaluated. He is currently at Hospital.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NH
- Alter
- 1,3
- Geschlecht
- M
- Eingang
- 03.08.2022
- Impfdatum
- 26.07.2022
- Beginn
- 26.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Diarrhoea
Incorrect dose administered
Irritability
Product administered to patient of inappropriate age
Symptomtext
Pediatric patient was inadvertently given adult dose of Hep A. Error was noticed right away, mom was notified and site was consulted as well as the nurse on duty. The website advised to monitor the child, the dose given counts as dose #1 and does not affect the timing on dose #2. Mom called 2 days later (7/28/22) and reported diarrhea and some crankiness. Nurse advised BRAT diet for diarrhea, and continue monitoring.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 53,0
- Geschlecht
- M
- Eingang
- 05.07.2022
- Impfdatum
- 23.06.2022
- Beginn
- 25.06.2022
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Herpes zoster
Rash
Symptomtext
Patient received varicella vaccine and two days later developed Shingles. He had a history of chickenpox he believes.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- 6/23/22 - received varicella vaccine 6/25/22 - developed Shingles rash
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none known
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 25.03.2022
- Impfdatum
- 22.03.2022
- Beginn
- 23.03.2022
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Injection site erythema
Injection site rash
Vomiting
Symptomtext
Patient received vaccination on 03/22/22 in the morning .Mom reported end of day on 03/24/22 that the patient developped redness on injection site followed by rash 1-2 days after receiving the vaccines. abd vomiting once. Denies fever chest pain or Shortness of breath. Patient was seen in clinic on 03/25/22 by a provider and had patchy endurated erythema. Provider assessment points to likely due to 1st dose of HPV vaccine
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- Pateint was prescribed Cetirizine and Hydrocortizone cream. Refered to see allergist due to previous allergy to ibuprofen resulting in hives as well.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Dyslipidemia Pre-diabetes Severe Obesity
- Andere Medikamente
- none
- Allergien
- Ibuprofen
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 18.03.2022
- Impfdatum
- 18.03.2022
- Beginn
- 18.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Urticaria
Symptomtext
thirty minutes after administration of series of vaccines patient broke out in mild hives. Benadryl 25mg PO liquid given. Rash then subsided within 45 minutes.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 3,0
- Geschlecht
- M
- Eingang
- 04.03.2022
- Impfdatum
- 26.02.2022
- Beginn
- 26.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash
Symptomtext
Patient broke out in full body rash around 1:45PM
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- 2/22/22 cough and congestion
- Vorgeschichte
- asthma
- Andere Medikamente
- unknown
- Allergien
- no known allergies
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 08.06.2023
- Impfdatum
- 08.06.2023
- Beginn
- 08.06.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Symptomtext
Patient's mother was notified within an hour and no treatment was needed.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 25,0
- Geschlecht
- M
- Eingang
- 26.01.2023
- Impfdatum
- 26.01.2023
- Beginn
- 26.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Underdose
Symptomtext
We gave the ped-adol dose of Hep A to the patient instead of the adult dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Underdose
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- Propranolol, Seroquel
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- -
- Geschlecht
- U
- Eingang
- 21.12.2022
- Impfdatum
- -
- Beginn
- 05.12.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Intercepted medication error
No adverse event
Product preparation issue
Symptomtext
No adverse event; He reconstituted VARIVAX with expired STERILE DILUENT but did not administer the dose to the patient; caller states that he reconstituted VARIVAX with expired STERILE DILUENT; This spontaneous report was received from Pharmacist and refers to a patient of an unknown age or gender. The patient's medical history, conditions and concomitant therapies were not reported. On 05-DEC-2022, a varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 milliliter, lot #U022320, expiration date: 15-JUL-2023 was reconstituted with an expired sterile diluent 0.5 milliliter, lot #T015779, expiration date: 02-DEC-2022 (Inappropriate preparation of medication). It was stated that after reconstituting the varicella virus vaccine live (oka/merck) (VARIVAX) the pharmacist realized that the sterile diluent was expired and did not administer the dose to the patient (Intercepted medication error). No additional adverse event was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 12.08.2022
- Impfdatum
- 08.08.2022
- Beginn
- 08.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SC / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Symptomtext
PATIENT WAS GIVEN A DOUBLE DOSE OF VARICELLA DUE TO RECEIVING PROQUAD AND VARIVAX. NO AFTER EFFECTS FROM DOUBLE DOSE.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 5,0
- Geschlecht
- F
- Eingang
- 06.08.2022
- Impfdatum
- 08.07.2022
- Beginn
- 08.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product preparation error
Symptomtext
No additional AEs were reported.; Medical assistant reported that a patient received a dose of VARIVAX which was reconstituted with polio vaccine (IPOL).; This spontaneous report was received from a medical assistant regarding a 5-year-old female patient. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 08-JUL-2022, the patient was vaccinated with a second dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 1 dose of 0.5 mL, lot #U022320, upon internal review the expiration date was established as 15-JUL-2023 (route of administration, and anatomical location were not provided) as prophylaxis, which was reconstituted with polio vaccine inactivated (reported as "IPOL") (4th dose, batch/lot #VIA021M) 0.5 mL (route of administration, expiration date and anatomical location were not provided) (Product preparation error). No additional adverse events were reported. The nurse mixed wrong vaccines instead of diluent, she did not pay attention to workflow. The vaccines had no experience temperature excursion reading from a digital data logger.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Prophylaxis
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 28.07.2022
- Impfdatum
- 16.06.2022
- Beginn
- 16.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
no adverse event; Caller reported that VARIVAX that underwent temperature excursions was administere; This spontaneous report was received from a licensed practical nurse referring to an unknown age and gender patient. No information regarding the patient's medical history, concurrent condition or concomitant therapy was provided. On 16-JUN-2022, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot number U022320, expiration date 15-JUL-2023) for prophylaxis (dose, administered route, strength and frequency were not reported) that after temperature excursion of 14 Fahrenheit (F) up to 46F for 13 hours 50 minutes and minus 58F to 5F (0.0F) for 6 hours 56 minutes (product storage error). There was no previous temperature excursion. No additional adverse events were reported (no adverse event). This is one of two reports received from the same reporter.; Sender's Comments: US-009507513-2207USA002160:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 28.07.2022
- Impfdatum
- 15.06.2022
- Beginn
- 15.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
no adverse event; Caller reported that VARIVAX that underwent temperature excursions was administere; This spontaneous report was received from a licensed practical nurse referring to an unknown age and gender patient. No information regarding the patient's medical history, concurrent condition or concomitant therapy was provided. On 15-JUN-2022, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot number U022320, expiration date 15-JUL-2023) for prophylaxis (dose, administered route, strength and frequency were not reported) that after temperature excursion of 14 Fahrenheit (F) up to 46F for 13 hours 50 minutes and minus 58 F to 5F (0.0F) for 6 hours 56 minutes (product storage error). There was no previous temperature excursion. No additional adverse events were reported (no adverse event). This is one of two reports received from the same reporter. ; Sender's Comments: US-009507513-2207USA002170:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- -
- Geschlecht
- U
- Eingang
- 09.06.2022
- Impfdatum
- 18.04.2022
- Beginn
- 18.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE reported; Improperly stored VARIVAX administered to patient; This spontaneous report was received from a healthcare business professional and refers to a patient of unknown age and gender. The patient's concurrent conditions, concomitant therapies and medical history were not provided. On 04-MAR-2022, there was a temperature excursion of -14 up to -10 degrees Celsius (-10.77?C) for 30 minutes, registered for varicella virus vaccine live (oka/merck) (VARIVAX). On 18-APR-2022, there was another temperature excursion of -11.45 degrees Celsius for 1 hour. On the same date, the patient was vaccinated with improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX), lot #U022320 has been verified to be a valid lot number for varicella virus vaccine live (oka/merck) (VARIVAX), expiration date: 15-JUL-2023 (strength, dose, route of administration, and anatomical location were not provided) administered for prophylaxis (product storage error). There was no additional adverse event reported (no adverse event).; Sender's Comments: US-009507513-2206USA000626: US-009507513-2205USA007031:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- -
- Geschlecht
- U
- Eingang
- 08.06.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
Healthcare Business Professional who was in charge of vaccine storage and stability.; No additional AE reported; This spontaneous report was received from a consumer referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with an improperly stored of varicella virus vaccine live (oka/merck) (VARIVAX) for prophylaxis (lot# U022320 has been verified to be a valid lot number varicella virus vaccine live (oka/merck), expiration date reported and establish as 15-JUL-2023) (strength, dose, route of administration and anatomical location were not provided). The temperature of storage and time frame of the excursion were -11.45? Celsius (C) for 1 hour respectively. If a digital data logger was involved was not reported. The vaccines experience a previous temperature excursion of -14?C up to -10?C for 30 minutes. No adverse event reported.; Sender's Comments: US-009507513-2205USA007031: US-009507513-2205USA007284:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- -
- Geschlecht
- U
- Eingang
- 28.05.2022
- Impfdatum
- -
- Beginn
- 18.04.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE reported.; Patient was administered improperly stored VARIVAX; This spontaneous report was received from a healthcare business professional and refers to a patient of unknown age and gender. The patient's concurrent conditions, concomitant therapies and medical history were not provided. On 18-APR-2022, the patient was vaccinated with improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U022320, expiration date: 15-JUL-2023 (strength, and route of administration were not provided) administered for prophylaxis (Product storage error). Administered vaccine experienced the temperature excursion of -11.45 degrees Celsius for 1 hour on 18-APR-2022 and -14 up to -10 degrees Celsius for 30 minutes on 04-MAR-2022. There was no adverse event reported (No adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 27.05.2022
- Impfdatum
- -
- Beginn
- 28.04.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE.; Nurse reporting VARIVAX was administered after a temperature excursion.; This spontaneous report has been received from a nurse concerning a patient of unreported age and gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions, or allergies, and concomitant medications were not provided. On 28-APR-2022, the patient was administered vaccine varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 milliliters (ml) (valid lot number U022320 [expiration date 15-JUL-2023]) for prophylaxis, after a temperature excursion of -12 degrees Celsius (C) for 24 hours (h) (product storage error) (dose number, vaccination scheme, frequency, route and anatomical location of vaccination were not provided). No previous temperature excursion was reported. No additional adverse events (AE) were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- U
- Eingang
- 07.05.2022
- Impfdatum
- 23.03.2022
- Beginn
- 23.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
No additional AE reported; A vaccine coordinator reported VARIVAX were administered after a temperature excursion.; This spontaneous report was received from a vaccine coordinator referring to a patient of unknown age and gender. Patient's concurrent conditions, pertinent medical history, concomitant medications, drug reactions and allergies were not reported. On 23-MAR-2022, the patient was vaccinated with an improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (lot number U022320 with expiration date: 15-JUL-2023), for prophylaxis (strength, dose, frequency, route of administration and anatomical location were not provided) (product storage error). It was reported that the suspect vaccine was exposed to a temperature excursion of minus 11.83 degrees Celsius for a time frame of 15 minutes. Previous temperature excursion was at 9.37 degree Celsius for a time frame of 2 hours and 30 min. No additional adverse events (AE) reported. This is one of several cases received from the same reporter.; Sender's Comments: US-009507513-2204USA004005:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 4,0
- Geschlecht
- U
- Eingang
- 22.04.2022
- Impfdatum
- 08.04.2022
- Beginn
- 08.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
No other issues or concerns noted; Varivax had a temperature excursion and had been administered; This spontaneous report was received from an office manager, referring to a patient of 4 year old of unknown gender. The patient's historical drugs, medical history, concomitant therapies and concurrent conditions were not reported. On 07-APR-2022, a temperature excursion was of -6.9 Centigrade degrees (?C), during 9 minutes occurred. A previous temperature excursion was not reported. On 08-APR-2022, the patient was vaccinated with an improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) lot# U022320, expiration date 15-JUL-2023, for prophylaxis (strength, dose, route and frequency were not reported). No other issues or concerns noted. This is one of 4 reports received from the same reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 4,0
- Geschlecht
- U
- Eingang
- 22.04.2022
- Impfdatum
- 11.04.2022
- Beginn
- 11.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
No other issues or concerns noted; Varivax had a temperature excursion and had been administered; This spontaneous report was received from an office manager, referring to a patient of4 year old of unknown gender. The patient's historical drugs, medical history, concomitant therapies and concurrent conditions were not reported. On 07-APR-2022, a temperature excursion was of -6.9 Centigrade degrees (?C), during 9 minutes occurred. A previous temperature excursion was not reported. On 11-APR-2022, the patient was vaccinated with an improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) lot# U022320, expiration date 15-JUL-2023, for prophylaxis (strength, dose, route and frequency were not reported). No other issues or concerns noted. This is one of 4 reports received from the same reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 4,0
- Geschlecht
- U
- Eingang
- 22.04.2022
- Impfdatum
- 14.04.2022
- Beginn
- 14.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
No other issues or concerns noted.; Varivax had a temperature excursion nad had been administered; This spontaneous report was received from an office manager, referring to a patient of 4 year old of unknown gender. The patient's historical drugs, medical history, concomitant therapies and concurrent conditions were not reported. On 07-APR-2022, a temperature excursion of -6.9 Centigrade degrees (?C), during 9 minutes occurred. A previous temperature excursion was not reported. On 14-APR-2022, the patient was vaccinated with an improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) lot# U022320, expiration date 15-JUL-2023, for prophylaxis (strength, dose, route and frequency were not reported) (product storage error). No other issues or concerns noted. This is one of 4 reports received from the same reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- -
- Geschlecht
- U
- Eingang
- 19.04.2022
- Impfdatum
- 08.04.2022
- Beginn
- 08.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Device connection issue
Needle issue
Underdose
Symptomtext
needle came loose and some of the vaccine spilled out; needle came loose and some of the vaccine spilled out; she is unsure if the patient received the entire dose; This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 08-APR-2022, the patient started therapy with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 ml (lot #U022320, has been verified to be a valid lot number, expiration date not reported, but upon internal validation established as 15-JUL-2023), administered for prophylaxis (route of administration were not provided). The nurse said that while administering a dose of varicella virus vaccine live (oka/merck) (VARIVAX) to a patient, the needle came loose (needle issue and device connection issue), and some of the vaccine spilled out. The nurse also reported that she was unsure if the patient received the entire dose (underdose).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Device connection issue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- U
- Eingang
- 15.04.2022
- Impfdatum
- 04.04.2022
- Beginn
- 04.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE reported; A vaccine coordinator reported VARIVAX was administered after a temperature excursion.; This spontaneous report was received from a vaccine coordinator referring to a patient of unknown age and gender. Concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On 04-APR-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) (strength, dose and route were not reported; lot # U022320, expiration date: 15-JUL-2023) for prophylaxis (product storage error). It was reported that the suspect vaccine was exposed to a temperature of minus 11.83 degree Celsius for a time frame of 15 minutes. Previous temperature excursion included 9.37 degree Celsius for a time frame of 2 hours and 30 min. No additional adverse event (AE) information was provided (no adverse event). This is one of the multiple cases reported by the same reporter.; Sender's Comments: US-009507513-2204USA002815:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- U
- Eingang
- 15.04.2022
- Impfdatum
- 02.04.2022
- Beginn
- 02.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE reported; A vaccine coordinator reported VARIVAX was administered after a temperature excursion.; This spontaneous report was received from a vaccine coordinator referring to a patient of unknown age and gender. Concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On 02-APR-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) (strength, dose and route were not reported; lot # U022320, expiration date: 15-JUL-2023) for prophylaxis (product storage error). It was reported that the suspect vaccine was exposed to a temperature of minus 11.83 degree Celsius for a time frame of 15 minutes. Previous temperature excursion included 9.37 degree Celsius for a time frame of 2 hours and 30 min. No additional adverse event (AE) information was provided (no adverse event). This is one of the multiple cases reported by the same reporter.; Sender's Comments: US-009507513-2204USA002815:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- U
- Eingang
- 15.04.2022
- Impfdatum
- 30.03.2022
- Beginn
- 30.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
No additional AE reported; A vaccine coordinator reported VARIVAX was administered after a temperature excursion.; This spontaneous report was received from a vaccine coordinator referring to a patient of unknown age and gender. Concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On 30-MAR-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) (strength, dose and route were not reported; lot # U022320, expiration date: 15-JUL-2023) for prophylaxis (product storage error). It was reported that the suspect vaccine was exposed to a temperature of minus 11.83 degree Celsius for a time frame of 15 minutes. Previous temperature excursion included 9.37 degree Celsius for a time frame of 2 hours and 30 min. No additional adverse event (AE) information was provided (no adverse event). This is one of the multiple cases reported by the same reporter.; Sender's Comments: US-009507513-2204USA002815:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- U
- Eingang
- 15.04.2022
- Impfdatum
- 25.03.2022
- Beginn
- 25.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE reported; A vaccine coordinator reported VARIVAX was administered after a temperature excursion.; This spontaneous report was received from a vaccine coordinator referring to a patient of unknown age and gender. Concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On 25-MAR-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) (strength, dose and route were not reported; lot # U022320, expiration date: 15-JUL-2023) for prophylaxis (product storage error). It was reported that the suspect vaccine was exposed to a temperature of minus 11.83 degree Celsius for a time frame of 15 minutes. Previous temperature excursion included 9.37 degree Celsius for a time frame of 2 hours and 30 min. No additional adverse event (AE) information was provided (no adverse event). This is one of the multiple cases reported by the same reporter.; Sender's Comments: US-009507513-2204USA002815:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 1,0
- Geschlecht
- F
- Eingang
- 29.03.2022
- Impfdatum
- 21.03.2022
- Beginn
- 21.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No other AE; temperature excursion, with subsequent administration; This spontaneous report was received from a healthcare provider and refers to a 1-year-old female patient. There was no information regarding patient's medical history, concurrent conditions and concomitant medications provided. On 21-MAR-2022, during 1-year well check, the patient was vaccinated with improperly stored doses of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (recombinant human albumin (rHA)) (M-M-R II) 0.5 milliliter, frequency: once, subcutaneously, lot# U006485, expiration date: 26-FEB-2023 and varicella virus vaccine live (Oka/Merck) (VARIVAX) 0.5 milliliter, frequency: once, subcutaneously, lot# U022320, expiration date: 15-JUL-2023, both for prophylaxis(indication also reported as "1-year-well check"). The aforementioned vaccines underwent a temperature excursion of 1 degree Celsius for 7 hours (product storage error) on an unknown date before administration. On an unspecified date, there were multiple previous temperature excursions. There were no lab diagnostic studies performed. The patient did not seek medical attention. No additional adverse events were reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 1,2
- Geschlecht
- F
- Eingang
- 18.03.2022
- Impfdatum
- 16.03.2022
- Beginn
- 16.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 1,3
- Geschlecht
- U
- Eingang
- 18.03.2022
- Impfdatum
- 03.03.2022
- Beginn
- 03.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional adverse events reported; a dose of VARlVAX has been administered to administered to a patient while being improperly stored on 03MAR2022; This spontaneous report was received from a certified medical assistant and refers to a 15-month-old patient of unknown gender. The patient's concurrent conditions, concomitant medications, medical history and drug allergies were not provided. On 03-MAR-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) in dose 0,5 ml, (lot # U022320, expiration date 15-JUL-2023) (formulation, route of administration and injection site were not provided) for prophylaxis. The temperature to which the vaccine was exposed was 13.4 degrees of Celsius (C) and the time frame was reported as 7 hours 55 minutes 0 seconds. No previous temperature excursion was reported. It was unknown if digital data logger was involved. No adverse events were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- -
- Geschlecht
- U
- Eingang
- 11.03.2022
- Impfdatum
- 04.03.2022
- Beginn
- 04.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE information provided; HBP in charge of vaccine storage calling to report that MMR II and VARIVAX were administered to a patient today 3/4/2022; This spontaneous report was received from an other health professional referring to a 57-week-old patient. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided. On 04-MAR-2022, the patient was vaccinated with improperly stored doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA)(M-M-R II) lot number U006485, expiration date 26-FEB-2023 and varicella virus vaccine live (oka/merck)(VARIVAX) lot number U022320, expiration date 15-JUL-2023 (doses and routes of administration not reported) both for prophylaxis (product storage error). No adverse event was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 22.02.2022
- Impfdatum
- 22.02.2022
- Beginn
- 22.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
Symptomtext
The second dose of hepatitis A vaccine was administered 24 weeks after the first dose instead of 6 calendar months.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- No
- Andere Medikamente
- No
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 02.01.2022
- Impfdatum
- 01.01.2022
- Beginn
- 01.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Interchange of vaccine products
Symptomtext
Patient was administered covid Pfizer vaccine on 1/1/22. Patient was already vaccinated with 2 moderna's elsewhere. Patient was seen by provider and is monitored by nurse for 24 hours. Patient denied any adverse signs or symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Interchange of vaccine products
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- Lactose Intolerant
- Vorherige Impfungen
- -